Straumann Holding AG (OTCMKTS:SAUHY) Receives Consensus Rating of “Hold” from Brokerages

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company.

Several analysts recently commented on the company. Barclays reaffirmed an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Citigroup restated a “sell” rating on shares of Straumann in a report on Thursday, July 9th. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. BMO Capital Markets began coverage on Straumann in a report on Wednesday, July 8th. They set an “outperform” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a report on Tuesday, June 30th.

Straumann Price Performance

Shares of OTCMKTS SAUHY opened at $12.59 on Friday. Straumann has a twelve month low of $9.44 and a twelve month high of $13.61. The company’s fifty day moving average is $12.55 and its 200-day moving average is $11.70.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.